| Literature DB >> 6369287 |
M K Chan, P Sweny, A M El Nahas, K Farrington, O N Fernando, J F Moorhead.
Abstract
Eight hypertensive renal allograft recipients who had received captopril are presented. Captopril in a maximal daily dose of 250 mg enabled the withdrawal of large doses of beta-blocking agents and vasodilators. Blood pressure was satisfactorily controlled in all except one. No adverse side effects were observed other than the 'first dose' effect which resulted in transient anuria in one patient. Captopril appears to be a useful agent in the management of severe hypertension after renal transplantation.Entities:
Mesh：
Substances：
Year: 1984 PMID： 6369287 PMCID： PMC2417707 DOI： 10.1136/pgmj.60.700.132
Source DB: PubMed Journal: Postgrad Med J ISSN： 0032-5473 Impact factor: 2.401